Consequences to patients, clinicians, and manufacturers when very serious adverse drug reactions are identified (1997–2019): A qualitative analysis from the Southern Network on Adverse Reactions (SONAR)
暂无分享,去创建一个
Benjamin L. Schooley | Matthew A. Taylor | P. Yarnold | K. Knopf | C. Bennett | J. Mckoy | C. Nabhan | O. Sartor | H. Thomsen | S. Rosen | Y. T. Yang | W. Hrushesky | N. Olivieri | K. Carson | William K. Smith | S. Ruggiero | D. Aboulafia | C. Migliorati | M. Schoen | S. Hoque | J. Restaino | Andrew C. Bennett | B. Witherspoon | Charles L. Bennett | Paul S. Ray | Marc L. Fishman | A. Godwin | Anne Ventrone | Courtney Lubaczewski | Henrik S. Thomsen | L. Martin | Jayanth Vemula | Henry C. Ausdenmoore | Georgne Herring | Juan Aldaco | Robert Marx | J. McKoy | Y. Yang | John Restaino